申请人:Roussel Uclaf
公开号:US04483868A1
公开(公告)日:1984-11-20
Diseases and ailments accompanied by gastric and gastroduodenal lesions treated by administering a compound of the formula (I) ##STR1## in which R represents hydrogen or alkyl containing 1 to 5 carbon atoms and R.sub.1 and R.sub.2, identical or different, both represent alkoxy containing 1 to 3 carbon atoms, or both represent halogen, or R.sub.1 represents hydrogen and R.sub.2 represents halogen, nitro or trifluoromethyl, or R.sub.1 and R.sub.2 form a methylenedioxy group at adjacent carbon atoms, as well as pharmaceutically acceptable salts thereof, particularly alkali metal, alkaline earth metal, or amine salts of said acid.
通过给予化合物(I)的治疗,治疗伴随有胃和胃十二指肠病变的疾病和疾患。其中R代表氢或含有1至5个碳原子的烷基,R.sub.1和R.sub.2,相同或不同,均代表含有1至3个碳原子的烷氧基,或均代表卤素,或R.sub.1代表氢,R.sub.2代表卤素、硝基或三氟甲基,或R.sub.1和R.sub.2在相邻碳原子上形成一个亚甲二氧基基团,以及其药学上可接受的盐,特别是所述酸的碱金属、碱土金属或胺盐。